 RADNOR, Pa., July 27, 2021 PRNewswire -- NRx Pharmaceuticals Nasdaq: NRXP NRx, a clinical stage, global biopharmaceutical company, today announced that the Nation of Georgias Prime Minister and Minister of Health have issued an Emergency Use Authorization for intravenous ZYESAMITM aviptadil for the treatment of Critical COVID-19. 